VMP 4053411000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Lansoprazole 15mg orodispersible tablets
BNF code 0103050L0AAAGAG
Virtual Therapeutic Moiety Lansoprazole
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 24 Aug 2005
Previous name Lansoprazole 15mg orodispersible gastro-resistant tablets
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Lansoprazole
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletdispersiblegastro-resistant.oral
Dose Form
Formulation Orodispersible tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Lansoprazole 15mg orodispersible tablets (AAH Hillcross)
Lansoprazole 15mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Lansoprazole 15mg orodispersible tablets (Lupin Healthcare (UK) Ltd)
Lansoprazole 15mg orodispersible tablets (Medihealth (Northern) Ltd)
Lansoprazole 15mg orodispersible tablets (Sigma Pharmaceuticals Plc)
Lansoprazole 15mg orodispersible tablets (Sun Pharmaceutical Industries Europe B.V.)
Lansoprazole 15mg orodispersible tablets (Viatris UK Healthcare Ltd)
Zoton FasTab 15mg (Pfizer Ltd)
Virtual Medicinal Product Packs
Lansoprazole 15mg orodispersible tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback